Parkinson's Disease

It is estimated that over one million Americans are affected by Parkinson's Disease. Recent research proposes that microvascular disorder hinders the blood flow to dopamine-producing neurons, thereby causing Parkinson's Disease. People with this condition might benefit from infusions of our treatment which, hopefully, could slow the progression of their disease or reverse the symptoms. Parkinson's Disease is an unmet medical need and Zhittya believes its drug treatment is a “disease modifying agent”, which means if Zhittya is correct, the drug treatment should address the root causes of the disease and not just the symptoms.